SCHEMBL6862911

SCHEMBL6862911

C[C@H](Nc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 11/20 0.58
THRA P10827 8/20 0.58
PPARG P37231 6/20 0.58
MEN1 O00255 5/20 0.58
KMT2A Q03164 5/20 0.58
LMNA P02545 4/20 0.58
TTR P02766 2/20 0.58
ADORA3 P0DMS8 2/20 0.58
PDE4D Q08499 2/20 0.58
HSD17B10 Q99714 2/20 0.58
RXRA P19793 2/20 0.58
NR1I2 O75469 2/20 0.58
NR3C1 P04150 1/20 0.58
CYP1A2 P05177 1/20 0.58
HTR1A P08908 1/20 0.58
CYP2C9 P11712 1/20 0.58
TBXA2R P21731 1/20 0.58
NTSR1 P30989 1/20 0.58
HTR2B P41595 1/20 0.58
USP2 O75604 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7112243 0.80 THRB (0.61) THRBTHRAPPARGMEN1KMT2A
SCHEMBL7112240 0.80 THRB (0.61) THRBTHRAPPARGMEN1KMT2A
SCHEMBL1525945 0.78 THRB (0.58) THRBTHRAPPARGMEN1KMT2A
SCHEMBL15500207 0.74 THRB (0.54) THRBTHRAPPARGMEN1KMT2A
SCHEMBL3217395 0.74 THRB (0.73) THRBTHRAPPARGMEN1KMT2A
SCHEMBL8196784 0.74 THRB (0.64) THRBTHRAPPARGMEN1KMT2A
SCHEMBL12764452 0.73 THRB (0.64) THRBTHRAPPARGMEN1KMT2A
SCHEMBL9522943 0.73 THRB (0.64) THRBTHRAPPARGMEN1KMT2A
Thyroxine SCHEMBL26147 0.73 THRB (1.00) THRBTHRAPPARGMEN1KMT2A
Thyroxine SCHEMBL4575383 0.73 THRB (1.00) THRBTHRAPPARGMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118265723-A Novel monoclonal antibodies directed against L-thyroxine and diagnostic uses thereof 豪夫迈·罗氏有限公司 2024-06-28 CN disclosed
US-20040030365-A1 Medical device to restore functions of a fibrillating heart by cardiac therapies remotely directed by a physician via two-way communication RUBIN LEO (US) 2004-02-12 US disclosed
EP-1339456-A2 A MEDICAL DEVICE TO RESTORE FUNCTIONS OF A FIBRILLATING HEART BY CARDIAC THERAPIES REMOTELY DIRECTED BY A PHYSICIAN VIA TWO-WAY COMMUNICATION Resuscitek, Inc. (US) 2003-09-03 EP disclosed
WO-2002045798-A2 A MEDICAL DEVICE TO RESTORE FUNCTIONS OF A FIBRILLATING HEART BY CARDIAC THERAPIES REMOTELY DIRECTED BY A PHYSICIAN VIA TWO-WAY COMMUNICATION RESUSCITEK, INC. (US) 2002-06-13 WO disclosed
US-5168102-A Administering thyroid hormone to decrease fat deposits UNIVERSITY OF DELAWARE (US) 1992-12-01 US disclosed
EP-0358754-A4 ENDOCRINE MANIPULATION TO IMPROVE BODY COMPOSITION OF POULTRY 1991-06-26 EP disclosed
US-4929600-A THYROID HORMONES, ANTIFAT AGENTS UNIVERSITY OF DELEWARE (US) 1990-05-29 US disclosed
EP-0358754-A1 ENDOCRINE MANIPULATION TO IMPROVE BODY COMPOSITION OF POULTRY UNIVERSITY OF DELAWARE (US) 1990-03-21 EP disclosed
WO-1989008458-A1 ENDOCRINE MANIPULATION TO IMPROVE BODY COMPOSITION OF POULTRY UNIVERSITY OF DELAWARE (US) 1989-09-21 WO disclosed